Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Bromoethanol | HCID 10898 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | HCID 118364744 | HCID 118364744 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 73504288 | HCID 73504288 | 144.3% |
Reaction Steps
(S)-2-((6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)methyl)-4-(5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyrimidin-2-yl)morpholine HCl salt 20 mg (0.04 mmol) was dissolved in dimethylformamide 1 ml, and 2-bromoethanol 6.6 mg (0.05 mmol) and K2CO3 15 mg (0.11 mmol) were added and then charged with nitrogen, followed by stirring at 60° C. for 4 hours. After the reaction, the reaction mixture was concentrated under reduced pressure to remove dimethylformamide, followed by extraction with EA and brine, and the organic layer was dried over MgSO4. Separation by column chromatography (methylene chloride:methanol=10:1) gave a product 33 mg (65%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09403831B2 |
|---|
| Source dataset | uspto-grants-2016_08 |
|---|
| ORD ID | ord-0158c5c7fd0340949e8c2a5966dc761b |
|---|
| Source note | uspto-grants-2016_08 |
|---|